Serum levels of tissue inhibitor of metalloproteinases 2 in systemic sclerosis: A preliminary study

Medical Science Monitor

Volumn 8, Issue 2, 2002, Pages

  Dziankowska Bartkowiak, Bozena ^a   Waszczykowska, Elzbieta ^a   Luczyńska, Maria ^a   Zalewska, Anna ^a   Sysa Jȩdrzejowska, Anna ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Pulmonary lesions; Raynaud's phenomenon; Scleroderma; TIMP 2

Indexed keywords

ANTINUCLEAR ANTIBODY; COLLAGEN; METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LUNG FIBROSIS; LUNG FUNCTION; MALE; RAYNAUD PHENOMENON; SCLERODERMA; SPIROMETRY; SYSTEMIC SCLEROSIS; THORAX RADIOGRAPHY;

ADOLESCENT; ADULT; AGED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; RAYNAUD DISEASE; RESPIRATORY FUNCTION TESTS; SCLERODERMA, SYSTEMIC; SKIN DISEASES; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 0036120948     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Pathogenesis of scleroderma: Cellular aspects
2. Serum tissue inhibitor of metalloproteinases in patients with systemic sclerosis
3. Scleroderma: Increased biosynthesis of triplehelical type I and type III procollagens associated with unaltered expression of collagenase in skin fibroblasts in culture
4. Decreased collagenase expression in cultured systemic sclerosis fibroblasts
5. Increased collagen synthesis by scleroderma skin fibroblasts in vitro: A possible defect in the regulation or activation of the scleroderma fibroblasts
6. Serum levels of tissue inhibitor of metalloproteinases 2 in patients with systemic sclerosis
7. Matrix metalloproteinases: Pro- and antiangiogenic activities
8. Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases: An application for rheumatoid arthritis serum and plasma
9. Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration
10. Serum metalloproteinases and their inhibitors: Markers for malignant potential
11. Preliminary criteria for the classification of systemic sclerosis (scleroderma)
12. Scleroderma (systemic sclerosis): Classification, subsets, and pathogenesis
13. A modified scleroderma skin score method
14. Badania czynnościowe ukladu oddechowego
15. Activation of tissue inhibitor of metalloproteinases-3 (TIMP-3) mRNA expression in scleroderma skin fibroblasts
16. Tissue inhibitor or metalloproteinase 1 (F1MP-1) may be an autocrine growth factor in scleroderma fibroblasts
17. Matrix metalloproteinases in skin
18. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4
19. Early detection of scleroderma spectrum disorders in patients with Raynaud's phenomenon
20. Connective tissue diseases characterized by fibrosis. Scleroderma (systemic sclerosis)
21. Connective tissue diseases characterized by fibrosis. Scleroderma
22. Factors predicting development of renal involvement in progressive systemic sclerosis